Zydus launches ANVIMO for prevention of CMV EP News Bureau Mar 5, 2025 Zydus has reduced the cost of Letermovir by 91 per cent of the innovator price. ANVIMO will be available in dosages of 240 mg and…
Lupin’s partner Concord gets US FDA nod to market Myfortic tablet Press Trust of India Dec 20, 2019 The tablets are indicated for prophylaxis of organ rejection in adult patients receiving kidney transplants Lupin said its…
